News/September 29, 2026

Observational study finds higher cortisol levels linked to accelerated cognitive decline in older adults — Evidence Review

Published in JAMA Network Open, by researchers from Rush

Researched byConsensus— the AI search engine for science

Table of Contents

Consistently high and irregular patterns of the stress hormone cortisol in saliva are linked to faster cognitive decline in older adults, according to a new longitudinal study. Related research generally supports these findings, indicating that salivary and blood-based biomarkers—especially those tied to stress or neurodegeneration—are promising tools for early detection of cognitive impairment and dementia, as discussed in the original study source.

  • Multiple studies report that elevated cortisol levels, whether measured in saliva, blood, or cerebrospinal fluid, are associated with cognitive deficits and may increase the risk for Alzheimer's disease and other dementias 6 7 9 10.
  • Salivary biomarkers beyond cortisol (such as beta-amyloid, tau, lactoferrin, and markers of oxidative stress) have also been shown to reliably indicate early cognitive impairment, supporting the utility of non-invasive saliva testing for brain health 1 2 4 5.
  • Chronic stress and dysregulated stress hormone patterns are linked to structural and functional changes in the brain, including in regions critical for memory and cognition, aligning with the observed associations between altered cortisol rhythms and cognitive decline 11 12 13 14 15.

Study Overview and Key Findings

Chronic stress is increasingly recognized as a factor in brain aging and cognitive decline, but reliable, non-invasive biomarkers for early detection and monitoring have been limited. This new study addresses that gap by examining the relationship between daily fluctuations in salivary cortisol—a key stress hormone—and cognitive decline in a diverse, community-based cohort over more than a decade. Notably, the research also explores racial differences in cortisol patterns and their implications for cognitive health, an area often underrepresented in previous studies.

Property Value
Study Year 2026
Organization Rush
Journal Name JAMA Network Open
Authors Ted K. S. Ng, Todd Beck, Yashwanth Sudhini, Robert S. Wilson, Denis A. Evans, Kumar B. Rajan
Population Older adults
Sample Size n=3895
Methods Observational Study
Outcome Cortisol levels and cognitive decline
Results Higher cortisol levels linked to faster cognitive decline.

To understand how these new findings fit into the broader research landscape, we searched the Consensus paper database (with over 200 million research papers) using the following queries:

  1. saliva test brain aging
  2. cortisol levels cognitive decline
  3. stress hormones brain function relationship

Below, we summarize the main themes and findings from relevant studies:

Topic Key Findings
How do cortisol levels relate to cognitive decline and dementia risk? - Elevated basal or morning cortisol is linked to cognitive deficits and increased risk for Alzheimer's disease and dementia 6 7 9 10.
- Flatter or dysregulated cortisol rhythms are associated with faster cognitive decline 6 7 9.
Can saliva serve as a reliable biomarker source for brain aging? - Salivary biomarkers (beta-amyloid, tau, lactoferrin, GSH) can support early diagnosis of Alzheimer's disease and differentiate between degrees of cognitive impairment 1 4 5.
- Saliva testing is non-invasive, repeatable, and shows clinical promise 3 5.
What are the mechanisms linking stress hormones to brain changes? - Chronic stress and elevated glucocorticoids can cause structural and functional brain changes, particularly in the hippocampus and prefrontal cortex 11 12 13 14 15.
- Genetic and environmental factors interact to modulate vulnerability 12 13.
Do cortisol patterns differ across populations or conditions? - Racial and demographic differences exist in cortisol patterns, which may reflect social and environmental stress exposure [new study].
- Dementia patients and those with depression show altered cortisol rhythms and higher overall levels 8 9.

How do cortisol levels relate to cognitive decline and dementia risk?

The new study’s finding that higher and more irregular salivary cortisol is associated with faster cognitive decline aligns with a robust body of literature. Both cross-sectional and longitudinal studies have consistently observed that elevated basal or morning cortisol levels are linked to poorer cognitive performance and an increased risk for dementia, including Alzheimer’s disease 6 7 9 10. Moreover, individuals with consistently high or flattened cortisol rhythms tend to experience faster rates of cognitive decline, supporting the new study’s focus on daily cortisol patterns.

  • Elevated basal or morning cortisol predicts deficits in memory, attention, and executive function in older adults 6 7 10.
  • Meta-analyses confirm that Alzheimer's patients have moderately increased salivary and blood cortisol, suggesting diagnostic value 9.
  • In dementia and mild cognitive impairment, higher cortisol is associated with more rapid cognitive decline 7 9.
  • The relationship between cortisol and cognitive decline persists even after accounting for other risk factors 6 9.

Can saliva serve as a reliable biomarker source for brain aging?

Saliva is emerging as a valuable, non-invasive medium for detecting biomarkers linked to neurodegeneration and aging. Multiple studies have identified proteins and metabolites (including beta-amyloid42, tau, lactoferrin, and glutathione) in saliva that correlate with early cognitive decline and dementia severity 1 4 5. The new study’s use of salivary cortisol builds on this trend, demonstrating that saliva can effectively reflect physiological processes relevant to brain health.

  • Salivary beta-amyloid42, tau, and lactoferrin reliably indicate early Alzheimer’s disease 1.
  • Salivary GSH can distinguish between mild, moderate, and severe dementia, correlating with cognitive status 4.
  • Saliva-based diagnostics are non-invasive, suitable for repeated testing, and may enable early intervention 3 5.
  • Advanced biosensors and point-of-care devices are under development to facilitate salivary biomarker monitoring 3 5.

What are the mechanisms linking stress hormones to brain changes?

The effects of chronic stress and dysregulated glucocorticoid (cortisol) signaling on the brain are well-documented. Stress hormones cross the blood-brain barrier and act on regions critical for memory and cognition, such as the hippocampus and prefrontal cortex 11 12 14. Prolonged elevation can lead to structural and functional changes, contributing to cognitive decline, neurodegeneration, and increased vulnerability to disorders like Alzheimer’s disease 13 15. The new study’s findings fit within this mechanistic framework.

  • Chronic stress and elevated cortisol are linked to hippocampal atrophy, reduced brain volumes, and impaired neuroplasticity 10 11 13.
  • Glucocorticoids regulate gene expression in the brain, affecting neuronal survival and synaptic function 12 13 14.
  • Environmental adversity and genetic susceptibility interact to modulate stress hormone effects 12 13.
  • Social support and physical activity may buffer the negative effects of chronic stress on the brain 11.

Do cortisol patterns differ across populations or conditions?

The new study is notable for examining racial differences in cortisol patterns, finding that Black participants had lower overall cortisol and flatter daily rhythms than white participants, but the association with cognitive decline was similar in both groups. This observation is consistent with research showing that social, economic, and environmental factors can shape stress hormone profiles across populations [new study]. Additionally, altered cortisol rhythms are observed in clinical populations such as dementia and depression patients 8 9.

  • Demographic and racial differences in cortisol may reflect chronic exposure to environmental stressors [new study].
  • Dementia patients show reduced diurnal variation and higher overall cortisol compared to controls 9.
  • Depression is associated with elevated cortisol and cognitive impairment, particularly in memory domains 8.
  • Understanding population-level differences in stress hormone patterns is important for developing equitable risk assessments [new study, 9].

Future Research Questions

While the current body of evidence supports the utility of salivary biomarkers and highlights the impact of stress hormones on cognitive aging, several important questions remain. Further research is needed to clarify causal mechanisms, improve diagnostic specificity, and address disparities in biomarker patterns across different populations.

Research Question Relevance
Can longitudinal salivary cortisol profiles predict conversion from mild cognitive impairment to dementia? Determining whether salivary cortisol patterns can serve as early warning markers for progression to dementia would improve preventative strategies and clinical management 7 9.
How do demographic and environmental factors influence cortisol rhythms and cognitive decline? Exploring these factors can help explain observed group differences and inform interventions aimed at reducing health disparities in cognitive aging [new study, 9].
What is the diagnostic accuracy of combined salivary biomarkers (e.g. cortisol, beta-amyloid, tau) for early Alzheimer’s disease? Assessing the value of multianalyte saliva panels could improve early diagnosis and risk stratification for Alzheimer’s disease, building on initial promising results 1 5.
Can interventions to reduce chronic stress or modulate cortisol levels slow cognitive decline in older adults? Testing whether behavioral or pharmacological interventions targeting stress pathways can preserve cognitive function would have significant clinical implications 7 11.
How do salivary cortisol patterns relate to other biological markers of brain aging? Understanding the interplay between cortisol and other biomarkers (e.g. oxidative stress, amyloid, tau) could clarify mechanisms of neurodegeneration and inform comprehensive screening panels 1 2 4.

Sources